Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Investigator-Initiated, Phase 4, Open-Label, Single-Arm, Single-Center Study Investigating the Residual Disease Memory in Psoriasis Skin During Enstilar® and Narrow-Band Ultraviolet B Therapy: The Mempsolar Study

NCT05185258 is registered in ClinicalTrials.gov with Aarhus University Hospital as lead sponsor.

NCT NCT05185258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05185258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Investigator-Initiated, Phase 4, Open-Label, Single-Arm, Single-Center Study Investigating the Residual Disease Memory in Psoriasis Skin During Enstilar® and Narrow-Band Ultraviolet B Therapy: The Mempsolar Study
Lead sponsor
Aarhus University Hospital
Phase
Phase 4
Overall status
Active, not recruiting
Start date
February 16, 2022
Completion date
July 15, 2026
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis, psoriasis vulgaris, skin and connective tissue diseases, skin diseases, skin diseases, papulosquamous